IL17A and epilepsy: Collectively, these findings support the view that IL-17 is an important pro-inflammatory mediator in epileptogenesis, especially in autoimmune-related epilepsy or epilepsy with intestinal immune imbalance, where the Th17/IL-17 pathway may play a critical role.